RecruitingNot ApplicableNCT04705038

Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments

A Feasibility Study of Orchiectomy in Patients With Prostate Cancer on Chronic LHRH Agonist or Antagonist Therapy


Sponsor

University of Chicago

Enrollment

100 participants

Start Date

Dec 18, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to learn how an educational intervention about orchiectomy as an alternative to medical castration for those who are already on medical castration will impact the number of patients willing to undergo an orchiectomy (surgery to remove the testicles).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing an educational intervention to help men with metastatic prostate cancer make more informed decisions about their treatment, specifically related to long-term hormone therapy (androgen deprivation therapy). Researchers want to know if education affects treatment choices and quality of life. **You may be eligible if...** - You have metastatic prostate cancer (adenocarcinoma) - You have been on continuous hormone therapy (LHRH agonist or antagonist) for at least 1 year with no plans to stop - You are able to complete written surveys in English **You may NOT be eligible if...** - You have had more than 2 systemic treatments beyond hormone therapy - You are not able to complete English-language surveys Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPatient Education

Brief educational session on surgical castration as an alternative to lifelong ADT for prostate cancer.


Locations(1)

University of Chicago Medicine Comprehensive Cancer Center

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04705038


Related Trials